http://www.btgplc.com/document/1034
BTG purchased TheraSphere last year, the only current competitor for Y90 beads, albeit glass and not resin. They currently hold an HDE in the US and are running a trial to get approval for secondary liver cancer treatment.
Turnover of TheraSphere was 24.7m UK pounds. From a total t/o of 79m for Interventional Medicine (they have some other products) the profit came in at 13.8m.
I'm surprised at the low T/O as I thought it would be nearer SRX levels based on Nordian reports for the past couple of years. Maybe there are supply issues from Canada.
Sorry this is as close as one can get to a proxy, IMO. others may have better data.
- Forums
- ASX - By Stock
- No more 1/4 dose sales
http://www.btgplc.com/document/1034 BTG purchased TheraSphere...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.66M |
Open | High | Low | Value | Volume |
15.0¢ | 15.5¢ | 15.0¢ | $58.71K | 378.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 2627800 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 84677 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2627800 | 0.150 |
4 | 991379 | 0.145 |
1 | 60000 | 0.140 |
1 | 40000 | 0.135 |
1 | 153846 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 84677 | 6 |
0.160 | 2398783 | 19 |
0.165 | 296786 | 10 |
0.170 | 99369 | 3 |
0.175 | 265000 | 2 |
Last trade - 12.34pm 10/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online